(Q34205792)

31 July 2017

Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis (English)

1 reference

31 July 2017

0 references

Limaye AP

1

1 reference

31 July 2017

Abrams JS

2

1 reference

31 July 2017

Silver JE

3

1 reference

31 July 2017

Awadzi K

4

1 reference

31 July 2017

Francis HF

5

1 reference

31 July 2017

Ottesen EA

6

1 reference

31 July 2017

Nutman TB

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 1991

1 reference

Journal of Clinical Investigation

31 July 2017

1 reference

31 July 2017

88

1 reference

31 July 2017

1418-1421

1 reference

31 July 2017

4

1 reference

The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

Ivermectin in the successful treatment of a patient with Mansonella ozzardi infection.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

Status of colony-stimulating factors in cancer and AIDS.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

Eosinophilia Following Treatment of Patients with Schistosomiasis Mansoni and Bancroft's Filariasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

In vivo administration of antibody to interleukin-5 inhibits increased generation of eosinophils and their progenitors in bone marrow of parasitized mice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=295614

Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF

28 October 2018

1 reference

12 December 2020

T cells from eosinophilic patients produce interleukin-5 with interleukin-2 stimulation

1 reference

12 December 2020

Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice

1 reference

12 December 2020

Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI115449

1 reference

31 July 2017

1 reference

31 July 2017

1 reference